vimarsana.com

Page 194 - ஆரோக்கியம் பராமரிப்பு ஆம்ப் மருத்துவமனைகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Co-Diagnostics, Inc to Present on Direct Saliva Testing Technology at Molecular Med Tri-Con

Share this article SALT LAKE CITY, Feb. 16, 2021 /PRNewswire/  Co-Diagnostics, Inc.  (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today that it will be presenting on direct saliva testing for COVID-19 at the 28 th Annual International Molecular Medicine Tri-Conference, held virtually on February 16-18, 2021. Company representatives will introduce the Co-Diagnostics Logix Smart SARS-CoV-2 DS (Direct Saliva) kit, which the Company has submitted for Emergency Use Authorization (EUA) to the US Food and Drug Administration (FDA). The virtual presentation will be webcast to conference attendees at 4:30 pm EST on Tuesday February 16

Vantage Hospice Encourages Advance Care Planning as Standard Practice

Vantage Hospice Encourages Advance Care Planning as Standard Practice A Rise in Business for One of Houston s Top Rated Hospice Practices Goes Hand in Hand with a Rise in Hospital Deaths Amidst the COVID-19 Pandemic News provided by Share this article Share this article HOUSTON, Feb. 16, 2021 /PRNewswire/  While 60% of businesses closed their doors permanently due to financial strain amidst the COVID-19 pandemic, business for one Houston-based company increased substantially. Patient-intake rose throughout 2020 for Vantage Hospice.  Sadly, so did the number of patients who died at hospitals, without hospice care, or the support of loved ones. Vantage Hospice Administrator, Nicole Knight, FNP believes that this is mostly due to society s unwillingness to talk about dying.

Us Against Alzheimer s advocacy group must reveal financial conflict of interest to FDA, says Dr Leslie Norins of Alzheimer s Germ Quest

Share this article Share this article NAPLES, Fla., Feb. 16, 2021 /PRNewswire/ The advocacy group Us Against Alzheimer s (UsA2) did not reveal in its January 19 letter to the FDA urging approval of aducanumab for Alzheimer s disease it had received monies from the drug s maker, Biogen, says Leslie Norins, MD, PhD, CEO of Alzheimer s Germ Quest.    For example, Biogen and its co-venturer, Esai, were both listed as Premier sponsors of the virtual Alzheimer s symposium presented by UsA2 in November 2020.  The premier designation was ranked even higher than platinum, but its cost was not given.  This is similar veiling to that of the Alzheimer s Association letter supporting approval of the same drug; significant contributions possibly millions of dollars to the association from Biogen and Esai were not disclosed, says Dr. Norins. 

Halo Collective Continues to Import to the United Kingdom, Now Offering Flower from Canada to UK Patients

Halo Collective Continues to Import to the United Kingdom, Now Offering Flower from Canada to UK Patients News provided by Share this article All figures in USD unless stated otherwise TORONTO, Feb. 16, 2021 /CNW/ - Halo Collective Inc. ( Halo or the Company ) (NEO: HALO) (OTCQX: HCANF formerly AGEEF) (Germany: A9KN) is pleased to announce further imports of Cannabis-Based Products for Medicinal use ( CBPMs ) to the United Kingdom via the Company s wholly-owned subsidiary Canmart Ltd ( Canmart ). While Canmart had previously imported tincture originating in the European Union ( EU ), its importation program has now expanded to flower products from Canada. Following the Company s acquisition of Canmart in November 2020, Halo is executing on its plan to import an assortment of CBPMs to qualified UK patients in search of high-quality medical cannabis.

A Meta-Analysis of Randomized Intervention Trials Confirms: MEMORY HEALTH® Patented Carotenoid Formula Improves Cognitive Performance and Protects Mental Functions, Even in Healthy Subjects

Share this article Share this article BIRMINGHAM, Mich., Feb. 16, 2021 /PRNewswire/  The analysis, by Davinelli et al., represents the first systematic review combining multiple randomized, double-blind, placebo-controlled studies known as the gold standard of clinical studies. This meta-analysis specifically evaluated studies of the effects of carotenoids on outcomes associated with cognitive performance, and included three separate randomized studies of the MEMORY HEALTH® carotenoid formula. Unlike other brain supplements, MEMORY HEALTH® was developed following over 20 years of scientific research on supplemental carotenoids. It was then independently tested in clinical trials on both healthy and demented brains [specifically patients with Alzheimer s disease], showing statistically significant improvements in brain health and cognitive function for everyone who took the supplement daily over a 18-month-period.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.